| Code | Description | Claims | Beneficiaries | Total Paid |
| 80053 |
Comprehensive metabolic panel |
15,514 |
13,916 |
$1.01M |
| 36415 |
Collection of venous blood by venipuncture |
10,019 |
8,343 |
$676K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,371 |
17,554 |
$577K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,907 |
4,769 |
$472K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,635 |
6,730 |
$419K |
| 87081 |
|
5,397 |
5,316 |
$327K |
| 81025 |
|
9,388 |
8,926 |
$322K |
| 86850 |
|
1,778 |
1,630 |
$303K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,111 |
2,616 |
$273K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,175 |
3,048 |
$242K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,741 |
5,591 |
$212K |
| 76830 |
Ultrasound, transvaginal |
1,538 |
1,497 |
$169K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,322 |
6,628 |
$161K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,267 |
1,242 |
$153K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,339 |
3,680 |
$150K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,482 |
2,828 |
$146K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,136 |
6,722 |
$124K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,928 |
2,789 |
$107K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,355 |
3,216 |
$106K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,410 |
1,383 |
$105K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,788 |
4,567 |
$92K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
795 |
760 |
$92K |
| 71046 |
Radiologic examination, chest; 2 views |
5,017 |
4,845 |
$88K |
| 87210 |
|
3,199 |
2,590 |
$81K |
| 87077 |
|
2,749 |
2,642 |
$77K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,830 |
10,243 |
$77K |
| 87428 |
|
1,308 |
1,274 |
$77K |
| 81001 |
|
10,604 |
9,903 |
$73K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,039 |
1,848 |
$70K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,433 |
2,336 |
$66K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,044 |
1,003 |
$65K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,100 |
1,068 |
$61K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,270 |
2,098 |
$59K |
| 81003 |
|
4,899 |
4,689 |
$56K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,323 |
9,581 |
$50K |
| 87400 |
|
642 |
620 |
$48K |
| 73610 |
|
1,034 |
1,002 |
$46K |
| 73130 |
|
473 |
458 |
$43K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
474 |
448 |
$41K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
945 |
921 |
$40K |
| 85610 |
|
2,690 |
2,150 |
$40K |
| 86900 |
|
1,965 |
1,788 |
$39K |
| 73630 |
|
1,003 |
970 |
$36K |
| 86780 |
|
2,431 |
2,267 |
$35K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
625 |
606 |
$35K |
| 82565 |
|
222 |
202 |
$34K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,219 |
2,076 |
$34K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
37 |
37 |
$30K |
| 84702 |
|
1,726 |
1,474 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
4,557 |
4,220 |
$30K |
| 71250 |
|
148 |
147 |
$29K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,204 |
1,173 |
$28K |
| 82950 |
|
1,288 |
1,257 |
$27K |
| 73564 |
|
784 |
752 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23,347 |
20,346 |
$24K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
242 |
242 |
$24K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
637 |
618 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,401 |
4,302 |
$24K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
198 |
191 |
$20K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
499 |
486 |
$20K |
| 73110 |
|
195 |
192 |
$19K |
| 74018 |
|
594 |
566 |
$19K |
| 59025 |
Fetal non-stress test |
453 |
309 |
$19K |
| 87070 |
|
262 |
254 |
$18K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
27 |
27 |
$17K |
| 83655 |
|
907 |
898 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,638 |
7,614 |
$14K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
321 |
308 |
$14K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,117 |
4,530 |
$14K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
581 |
554 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,802 |
3,643 |
$11K |
| 73030 |
|
367 |
354 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,318 |
4,472 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
664 |
632 |
$9K |
| 72100 |
|
336 |
330 |
$8K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,353 |
1,334 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,237 |
2,090 |
$6K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
54 |
53 |
$6K |
| 76801 |
|
537 |
484 |
$6K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
26 |
26 |
$6K |
| 93017 |
|
106 |
105 |
$6K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
71 |
48 |
$5K |
| 80076 |
|
1,209 |
1,118 |
$5K |
| G0378 |
Hospital observation service, per hour |
1,505 |
1,232 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
69 |
69 |
$5K |
| 85027 |
|
3,475 |
3,217 |
$4K |
| 80061 |
Lipid panel |
1,766 |
1,720 |
$4K |
| 83001 |
|
106 |
101 |
$4K |
| 85018 |
|
1,526 |
1,497 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
424 |
422 |
$4K |
| 84484 |
|
4,804 |
4,061 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
206 |
189 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
29 |
29 |
$3K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
111 |
109 |
$3K |
| 82728 |
|
223 |
220 |
$2K |
| 96376 |
|
1,921 |
1,371 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
529 |
338 |
$2K |
| 80047 |
|
115 |
109 |
$2K |
| 83986 |
|
30 |
30 |
$2K |
| 87807 |
|
301 |
299 |
$2K |
| 83690 |
|
5,746 |
5,206 |
$2K |
| 85379 |
|
1,478 |
1,409 |
$2K |
| 85007 |
|
537 |
503 |
$2K |
| 82105 |
|
126 |
115 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,885 |
1,606 |
$2K |
| 86762 |
|
1,177 |
1,063 |
$2K |
| 83540 |
|
278 |
269 |
$2K |
| 82570 |
|
549 |
487 |
$2K |
| 86803 |
|
1,179 |
1,107 |
$1K |
| 82247 |
|
112 |
68 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,583 |
1,357 |
$1K |
| 83735 |
|
3,857 |
3,102 |
$1K |
| 84439 |
|
256 |
243 |
$1K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
165 |
134 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
67 |
66 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,082 |
1,569 |
$1K |
| 84146 |
|
56 |
54 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,546 |
2,376 |
$1K |
| 72040 |
|
27 |
26 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
269 |
265 |
$980.92 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,558 |
4,780 |
$931.63 |
| 74022 |
|
56 |
54 |
$929.06 |
| 93976 |
|
715 |
688 |
$884.75 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,280 |
5,038 |
$860.44 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,504 |
4,266 |
$830.95 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
170 |
162 |
$794.35 |
| 83605 |
|
1,908 |
1,685 |
$732.33 |
| 73502 |
|
37 |
37 |
$704.67 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,134 |
558 |
$704.64 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
834 |
769 |
$665.11 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
246 |
226 |
$652.84 |
| 76775 |
|
12 |
12 |
$600.30 |
| 82607 |
|
124 |
120 |
$579.41 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,041 |
972 |
$560.13 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
432 |
406 |
$528.21 |
| 86140 |
|
1,774 |
1,664 |
$509.64 |
| 83880 |
|
1,715 |
1,573 |
$426.05 |
| J3490 |
Unclassified drugs |
3,366 |
2,199 |
$418.90 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,610 |
5,730 |
$393.25 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
313 |
302 |
$371.14 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
55 |
52 |
$360.26 |
| 82077 |
|
514 |
485 |
$349.33 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
470 |
394 |
$341.89 |
| 88141 |
|
17 |
17 |
$331.98 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
524 |
370 |
$286.71 |
| 86787 |
|
749 |
697 |
$246.69 |
| 87177 |
|
29 |
25 |
$197.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,839 |
1,595 |
$193.26 |
| 86901 |
|
1,963 |
1,788 |
$159.93 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,368 |
1,249 |
$155.09 |
| 87340 |
|
1,394 |
1,270 |
$152.07 |
| 82550 |
|
28 |
25 |
$132.17 |
| 86308 |
|
13 |
13 |
$125.89 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
107 |
97 |
$102.71 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
46 |
24 |
$86.11 |
| 76000 |
|
12 |
12 |
$83.02 |
| 73090 |
|
17 |
17 |
$72.35 |
| 83020 |
|
186 |
154 |
$51.76 |
| 87040 |
|
426 |
383 |
$46.42 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,018 |
2,416 |
$46.20 |
| 86317 |
|
111 |
83 |
$37.48 |
| 84550 |
|
93 |
80 |
$32.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,303 |
2,154 |
$27.49 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,701 |
4,361 |
$26.04 |
| 82784 |
|
17 |
12 |
$11.27 |
| 87186 |
|
1,802 |
1,719 |
$11.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
698 |
587 |
$7.96 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,039 |
942 |
$5.97 |
| 84156 |
|
282 |
244 |
$4.73 |
| 85651 |
|
423 |
396 |
$4.71 |
| 84100 |
|
941 |
759 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
25 |
25 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
130 |
125 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
80 |
63 |
$0.00 |
| 97163 |
|
25 |
24 |
$0.00 |
| 90715 |
|
58 |
57 |
$0.00 |
| 82248 |
|
176 |
111 |
$0.00 |
| 84145 |
|
161 |
146 |
$0.00 |
| 84466 |
|
263 |
254 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
38 |
30 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
155 |
151 |
$0.00 |
| 80143 |
|
29 |
27 |
$0.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
37 |
26 |
$0.00 |
| 94664 |
|
15 |
13 |
$0.00 |
| 86682 |
|
18 |
16 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
128 |
60 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
40 |
39 |
$0.00 |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
14 |
14 |
$0.00 |
| 87209 |
|
29 |
25 |
$0.00 |
| 73590 |
|
12 |
12 |
$0.00 |
| 80179 |
|
13 |
13 |
$0.00 |
| 85730 |
|
561 |
519 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
636 |
573 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
224 |
206 |
$0.00 |
| 85652 |
|
551 |
515 |
$0.00 |
| 83615 |
|
76 |
65 |
$0.00 |
| 87205 |
|
172 |
165 |
$0.00 |
| 86704 |
|
109 |
81 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
55 |
24 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
24 |
24 |
$0.00 |
| 88304 |
|
13 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
30 |
30 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
59 |
56 |
$0.00 |